ACC CardiaCast: What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten

ACC CardiaCast - Podcast tekijän mukaan American College of Cardiology - Perjantaisin

kokeile Podimo ilmaiseksi 30 päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

Sponsored

In this episode, Drs. Matt Martinez and Theodore Abraham discuss “What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten” for the treatment of hypertrophic cardiomyopathy, and its mechanisms of action.

Visit the podcast's native language site